Participate in polls relating to real-time continuous glucose monitoring and see how your answers relate to your colleagues.


The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) trial found that:
CGM significantly decreased diabetes distress
CGM significantly enhanced hypoglycemic confidence
CGM significantly improved both diabetes distress and hypoglycemic confidence
CGM significantly improved patients' well-being
CGM significantly improved patients' health status

Submit
cgmEDUCATION.net is supported by independent educational grants from Ascensia Diabetes Care, Insulet Corporation and Medtronic.
©2022 CogniMed Inc. All rights reserved.